MAM
WST icon

Marquette Asset Management’s West Pharmaceutical WST Stock Holding History

Marquette Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$2.48K – 916
2025
Q4 		$2.48K Hold
9
– – ﹤0.01% 447
2025
Q3 		$2.36K Buy
+9
New +$2.19K ﹤0.01% 500
2022
Q3 		– Sell
-1
Closed – – 400
2022
Q2 		$0 Hold
1
– – ﹤0.01% 439
2022
Q1 		$0 Buy
+1
New +$391 ﹤0.01% 398

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marquette Asset Management's WST Position: Q1 2026 in Review

Marquette Asset Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 9 shares — an estimated $2.48K sold.

Marquette Asset Management first reported a position in WST in Q1 2022 and held it in 4 quarters. The position peaked at $2.48K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Marquette Asset Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Marquette Asset Management sold 9 West Pharmaceutical shares in Q1 2026, an estimated $2.48K.
  • Marquette Asset Management first reported a position in West Pharmaceutical in Q1 2022 and held it in 4 quarters.
  • Marquette Asset Management's West Pharmaceutical position peaked at $2.48K in Q4 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Marquette Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.